<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01539694</url>
  </required_header>
  <id_info>
    <org_study_id>744E</org_study_id>
    <nct_id>NCT01539694</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Product Performance of a Low Add MultiFocal Soft Contact Lens</brief_title>
  <official_title>A Study to Evaluate the Product Performance of a Low Add MultiFocal Soft Contact Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bausch &amp; Lomb Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the product performance of an investigational&#xD;
      multifocal low add soft contact lens.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>At 1 week follow up</time_frame>
    <description>Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptoms/Complaints</measure>
    <time_frame>At 1 week follow up</time_frame>
    <description>Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Presbyopia</condition>
  <arm_group>
    <arm_group_label>LD118033 contact lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational LD118033 multifocal low add soft contact lenses, to be worn on a daily wear basis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PureVision multifocal contact lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>PureVision multifocal low add soft contact lens, to be worn on a daily wear basis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LD118033 contact lens</intervention_name>
    <description>Multifocal contact lens worn on a daily wear basis for 1 week</description>
    <arm_group_label>LD118033 contact lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PureVision multifocal contact lens</intervention_name>
    <description>PureVision multifocal contact lens worn on a daily wear basis for 1 week.</description>
    <arm_group_label>PureVision multifocal contact lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Have physiologically normal anterior segments.&#xD;
&#xD;
          -  Be adapted wearers of soft contact lenses and wear a lens in each eye.&#xD;
&#xD;
          -  Be presbyopic and require near add correction in each eye.&#xD;
&#xD;
          -  Have no active ocular disease or allergic conjunctivitis.&#xD;
&#xD;
          -  Must not be using any topical ocular medications.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any Grade 2 or greater finding during the slit lamp examination.&#xD;
&#xD;
          -  Any scar or neovascularization within the central 4mm of the cornea.&#xD;
&#xD;
          -  Any &quot;Present&quot; finding during the slit lamp examination that, in the Investigator's&#xD;
             judgment, interferes with contact lens wear.&#xD;
&#xD;
          -  Allergic to any component in the study products.&#xD;
&#xD;
          -  Any systemic disease affecting ocular health.&#xD;
&#xD;
          -  Using any systemic or topical medications that will affect ocular physiology or lens&#xD;
             performance.&#xD;
&#xD;
          -  An active ocular disease, any corneal infiltrative response or are using any ocular&#xD;
             medications.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerard Cairns, PhD, MCOptom</last_name>
    <role>Study Director</role>
    <affiliation>Bausch &amp; Lomb Incorporated</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bausch &amp; Lomb Incorporated</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>February 15, 2012</study_first_submitted>
  <study_first_submitted_qc>February 22, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2012</study_first_posted>
  <results_first_submitted>August 21, 2020</results_first_submitted>
  <results_first_submitted_qc>September 9, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 30, 2020</results_first_posted>
  <last_update_submitted>September 9, 2020</last_update_submitted>
  <last_update_submitted_qc>September 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>A total of 126 participants (252 eyes) were enrolled. One-half of the participants were randomized to receive the investigational contact lens during the first crossover period, and the other half were randomized to receive the PureVision contact lens during the first crossover period. The participants crossed over to the other group at 1 week.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>LD118033 Contact Lens Then PureVision Multifocal Contact Lens</title>
          <description>Investigational LD118033 multifocal low add soft contact lenses, to be worn on a daily wear basis.&#xD;
LD118033 contact lens: Multifocal contact lens worn on a daily wear basis for 1 week&#xD;
PureVision multifocal low add soft contact lens, to be worn on a daily wear basis.&#xD;
PureVision multifocal contact lens: PureVision multifocal contact lens worn on a daily wear basis for 1 week</description>
        </group>
        <group group_id="P2">
          <title>PureVision Multifocal Contact Lens Then LD118033 Contact Lens</title>
          <description>PureVision multifocal low add soft contact lens, to be worn on a daily wear basis.&#xD;
PureVision multifocal contact lens: PureVision multifocal contact lens worn on a daily wear basis for 1 week.&#xD;
Investigational LD118033 multifocal low add soft contact lenses, to be worn on a daily wear basis.&#xD;
LD118033 contact lens: Multifocal contact lens worn on a daily wear basis for 1 week</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="63"/>
                <participants group_id="P2" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
                <participants group_id="P2" count="62"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Demography was collected for 124 eligible, dispensed participants. Participants received both treatment groups.</population>
      <group_list>
        <group group_id="B1">
          <title>Overall</title>
          <description>All participants/eyes received both treatment groups.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="124"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47.0" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="93"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity</title>
        <description>Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).</description>
        <time_frame>At 1 week follow up</time_frame>
        <population>There were 124 eligible, dispensed participants (248 eyes). Participants/eyes received both treatment groups.</population>
        <group_list>
          <group group_id="O1">
            <title>LD118033 Contact Lens</title>
            <description>Investigational LD118033 multifocal low add soft contact lenses, to be worn on a daily wear basis.&#xD;
LD118033 contact lens: Multifocal contact lens worn on a daily wear basis for 1 week</description>
          </group>
          <group group_id="O2">
            <title>PureVision Multifocal Contact Lens</title>
            <description>PureVision multifocal low add soft contact lens, to be worn on a daily wear basis.&#xD;
PureVision multifocal contact lens: PureVision multifocal contact lens worn on a daily wear basis for 1 week.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity</title>
          <description>Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).</description>
          <population>There were 124 eligible, dispensed participants (248 eyes). Participants/eyes received both treatment groups.</population>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="124"/>
                <count group_id="O2" value="124"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="248"/>
                <count group_id="O2" value="248"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.023" spread="0.078"/>
                    <measurement group_id="O2" value="0.005" spread="0.069"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Symptoms/Complaints</title>
        <description>Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.</description>
        <time_frame>At 1 week follow up</time_frame>
        <population>There were 124 eligible, dispensed participants (248 eyes). Participants/eyes received both treatment groups.</population>
        <group_list>
          <group group_id="O1">
            <title>LD118033 Contact Lens</title>
            <description>Investigational LD118033 multifocal low add soft contact lenses, to be worn on a daily wear basis.&#xD;
LD118033 contact lens: Multifocal contact lens worn on a daily wear basis for 1 week</description>
          </group>
          <group group_id="O2">
            <title>PureVision Multifocal Contact Lens</title>
            <description>PureVision multifocal low add soft contact lens, to be worn on a daily wear basis.&#xD;
PureVision multifocal contact lens: PureVision multifocal contact lens worn on a daily wear basis for 1 week.</description>
          </group>
        </group_list>
        <measure>
          <title>Symptoms/Complaints</title>
          <description>Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.</description>
          <population>There were 124 eligible, dispensed participants (248 eyes). Participants/eyes received both treatment groups.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="124"/>
                <count group_id="O2" value="124"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="248"/>
                <count group_id="O2" value="248"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Burning/stinging upon insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.3" spread="12.6"/>
                    <measurement group_id="O2" value="89.2" spread="16.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Comfort upon insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.0" spread="16.6"/>
                    <measurement group_id="O2" value="83.9" spread="18.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Comfort at end of day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.5" spread="24.4"/>
                    <measurement group_id="O2" value="68.1" spread="25.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.2" spread="21.2"/>
                    <measurement group_id="O2" value="74.6" spread="22.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dryness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.7" spread="22.4"/>
                    <measurement group_id="O2" value="75.2" spread="23.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Itchiness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.1" spread="17.0"/>
                    <measurement group_id="O2" value="84.5" spread="21.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.9" spread="12.3"/>
                    <measurement group_id="O2" value="87.0" spread="18.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Distance Vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.3" spread="30.4"/>
                    <measurement group_id="O2" value="76.5" spread="23.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vision at intermediate distance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.2" spread="20.3"/>
                    <measurement group_id="O2" value="80.7" spread="18.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vision at near distance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.3" spread="25.7"/>
                    <measurement group_id="O2" value="72.2" spread="26.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.9" spread="25.8"/>
                    <measurement group_id="O2" value="73.7" spread="22.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ease of handling/insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.7" spread="18.8"/>
                    <measurement group_id="O2" value="85.4" spread="19.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ease of handling/removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.5" spread="17.2"/>
                    <measurement group_id="O2" value="87.5" spread="17.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall impression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.7" spread="24.0"/>
                    <measurement group_id="O2" value="74.6" spread="22.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 weeks</time_frame>
      <desc>Adverse events (AEs) were not coded. Therefore, source vocabulary is not applicable. A total of 126 participants (252 eyes) were assessed for AEs. Participants/eyes received both treatment groups in this cross-over study.</desc>
      <group_list>
        <group group_id="E1">
          <title>LD118033 Contact Lens</title>
          <description>Investigational LD118033 multifocal low add soft contact lenses, to be worn on a daily wear basis.&#xD;
LD118033 contact lens: Multifocal contact lens worn on a daily wear basis for 1 week</description>
        </group>
        <group group_id="E2">
          <title>PureVision Multifocal Contact Lens</title>
          <description>PureVision multifocal low add soft contact lens, to be worn on a daily wear basis.&#xD;
PureVision multifocal contact lens: PureVision multifocal contact lens worn on a daily wear basis for 1 week.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="126"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="126"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Contact sponsor directly for details.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Study Director</name_or_title>
      <organization>Bausch Health</organization>
      <email>robert.steffen@bausch.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

